NCT06757010 - A Study of NE3107 in Early Parkinson's | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 26, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

January 2, 2026

Conditions

Parkinsons Disease (PD)

Interventions

DRUG

NE3107

NE3107 20 mg BID

DRUG

Placebo

Placebo BID

Trial Locations (4)

RECRUITING

Dent Neurologic, Amherst

RECRUITING

Science 37 (Nationwide Site), Morrisville

RECRUITING

NeuroScience Research Center, LLC, Canton

RECRUITING

Quest Research Institute, Farmington Hills